These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 399955)

  • 1. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human gastric juice on the mutagenicity of chemicals.
    De Flora S; Boido V
    Mutat Res; 1980 Apr; 77(4):307-15. PubMed ID: 6990248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test].
    Khudoleĭ VV; Bartsch H; Malaveille C
    Vopr Onkol; 1981; 27(12):47-51. PubMed ID: 7034364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues.
    Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S
    Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of sodium-azide mutagenicity by liver preparations and by gastric juice.
    de Flora S; Coppola R; Zanacchi P; Bennicelli C
    Mutat Res; 1979 Jul; 61(2):387-92. PubMed ID: 384225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of some lipsticks and their dyes.
    Green MR; Pastewka JV
    J Natl Cancer Inst; 1980 Mar; 64(3):665-9. PubMed ID: 6986498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity experiments on agroclavines, new natural antineoplastic compounds.
    Glatt H; Eich E; Pertz H; Becker C; Oesch F
    Cancer Res; 1987 Apr; 47(7):1811-4. PubMed ID: 3545454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
    Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
    Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
    [No Abstract]   [Full Text] [Related]  

  • 15. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens.
    Moriya M; Ohta T; Sugiyama F; Miyazawa T; Shirasu Y
    J Natl Cancer Inst; 1979 Oct; 63(4):977-82. PubMed ID: 384011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative studies on the Salmonella/microsome mutagenicity assay.
    Dunkel VC
    J Assoc Off Anal Chem; 1979 Jul; 62(4):874-82. PubMed ID: 387710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of diallate, sulfallate, and triallate and relationship between structure and mutagenic effects of carbamates used widely in agriculture.
    De Lorenzo F; Staiano N; Silengo L; Cortese R
    Cancer Res; 1978 Jan; 38(1):13-5. PubMed ID: 201368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes.
    Shimada T; Guengerich FP
    Cancer Res; 1990 Apr; 50(7):2036-43. PubMed ID: 2180560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.